Korean Association of Traditional Oncology

Cancer treatment is one of the greatest challenges humanity faces, and traditional Korean medicine has continuously sought new directions to address this challenge. With the passion and efforts of medical doctor of Korean medicine, Korean medicine cancer treatment has been evolving for over 30 years.

Here, 2024 KATO spring conference is organized under the theme of "Latest Insights in Korean Medicine for Cancer Treatment," inviting experts in various types of cancer to share their diverse research findings and clinical experiences.

In particular, we are honored to have special lectures by Dr. Tingbao, a oncologist actively conducting research at the Dana-Farber Cancer Institute under Harvard Medical School in the United States, and Professor Myung-Han Hyun, an oncologist and director of the Integrated Cancer Care Center at Ilsan Cha Hospital. These lectures are expected to provide a global and integrated perspective on cancer treatment.

Additionally, we have organized sessions to educate clinicians on the latest insights into traditional Korean medicine treatments for common cancers such as prostate cancer, gynecologic cancers, breast cancer, and thyroid cancer, enabling them to treat with confidence based on evidence.

In conclusion, I would like to extend my gratitude to all of you for attending this conference despite your busy schedules. Your enthusiastic participation and active discussions will make this conference even more meaningful and successful.

With this conference, I hope that both Korean medicine can achieve greater advancements in cancer treatment through integration and convergence, providing new hope to many cancer patients.

President of KATO
Hwa Seung Yoo, KMD, PhD
(Seoul Korean Medicine Hospital of Daejeon University)